N
Market Data
$27.34−$2.30 (−7.76%)
NAMS · Last trade
Prev Close
$29.64
Range (29d)
$26.67 – $30.22
Recent Filings
- 144/A5.1 KBNewAmsterdam Pharma Co N.V.Aug 25, 4:47 PM ET·0001968582-26-000878
- 1445.0 KBNewAmsterdam Pharma Co N.V.Aug 24, 4:55 PM ET·0001968582-26-000868
- 8-K/A214.0 KBNewAmsterdam Pharma Co N.V.Aug 14, 4:10 PM ET·0001193125-26-352233
- 8-K207.1 KBNewAmsterdam Pharma Co N.V.Aug 14, 4:05 PM ET·0001193125-26-352186
- SCHEDULE 13G/A11.7 KBNewAmsterdam Pharma Co N.V.Aug 6, 10:33 AM ET·0000315066-26-002082
- 8-K868.2 KBNewAmsterdam Pharma Co N.V.Aug 5, 7:08 AM ET·0001193125-26-333827
- 10-Q7.7 MBNewAmsterdam Pharma Co N.V.Aug 5, 7:06 AM ET·0001193125-26-333824
- 8-K249.8 KBNewAmsterdam Pharma Co N.V.Jul 24, 8:03 AM ET·0001193125-26-315163
- 8-K202.2 KBNewAmsterdam Pharma Co N.V.Jul 22, 4:05 PM ET·0001193125-26-312390
- 8-K465.7 KBNewAmsterdam Pharma Co N.V.Jun 3, 7:58 AM ET·0001193125-26-254615
Insiders
10- Audet Juliette BerangereSee Remarks
- Bain Capital Life Sciences Fund III, L.P.10% Owner
- Bain Capital Life Sciences Fund II, L.P.10% Owner
- Bain Capital Life Sciences Investors, LLC10% Owner
- BCIP Life Sciences Associates, LP10% Owner
- BCLS Fund III Investments, LP10% Owner
- BCLS II Investco, LP10% Owner
- Davidson Michael H.Director, Chief Executive Officer
- Downing NicholasDirector
- Forbion Capital Fund IV Cooperatief U.A.10% Owner
Tickers
Addresses
business
GOOIMEER 2-35
NARRDEN, P7, 1411 DC
mailing
GOOIMEER 2-35
NARRDEN, P7, 1411 DC
Former Names
- NewAmsterdam Pharma Co B.V.2022-11-22